BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27364575)

  • 1. Mesorectal Invasion Depth in Rectal Carcinoma Is Associated With Low Survival.
    Lino-Silva LS; Loaeza-Belmont R; Gómez Álvarez MA; Vela-Sarmiento I; Aguilar-Romero JM; Domínguez-Rodríguez JA; Salcedo-Hernández RA; Ruiz-García EB; Maldonado-Martínez HA; Herrera-Gómez Á
    Clin Colorectal Cancer; 2017 Mar; 16(1):73-77. PubMed ID: 27364575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer.
    Shin R; Jeong SY; Yoo HY; Park KJ; Heo SC; Kang GH; Kim WH; Park JG
    Dis Colon Rectum; 2012 Dec; 55(12):1220-8. PubMed ID: 23135579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer].
    Shen L; Tong T; Zhang H; Sun Y; Zhu J; Cai G; Li G; Liang L; Cai X; Fan M; Huang J; Yang L; Sun W; Cai S; Zhang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):551-5. PubMed ID: 24953360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.
    Merkel S; Weber K; Schellerer V; Göhl J; Fietkau R; Agaimy A; Hohenberger W; Hermanek P
    Br J Surg; 2014 Apr; 101(5):566-72. PubMed ID: 24477831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal.
    Cho SH; Kim SH; Bae JH; Jang YJ; Kim HJ; Lee D; Park JS;
    AJR Am J Roentgenol; 2014 Jun; 202(6):1238-44. PubMed ID: 24848820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion.
    Wilkins S; Haydon A; Porter I; Oliva K; Staples M; Carne P; McMurrick P; Bell S
    Dis Colon Rectum; 2016 May; 59(5):361-8. PubMed ID: 27050597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study.
    Song JH; Kim SH; Lee JH; Cho HM; Kim DY; Kim TH; Kim SY; Baek JY; Oh JH; Nam TK; Yoon MS; Jeong JU; Kim K; Chie EK; Jang HS; Kim JS; Kim JH; Kang KM
    Radiother Oncol; 2016 Feb; 118(2):387-92. PubMed ID: 26763136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation.
    Sun Y; Li J; Shen L; Wang X; Tong T; Gu Y
    Diagn Interv Radiol; 2018; 24(3):128-134. PubMed ID: 29770764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
    Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
    Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
    Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
    Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the radiation-induced regression of positive nodes on survival in patients with rectal cancer treated with chemoradiotherapy.
    Beppu N; Kakuno A; Doi H; Kamikonya N; Matsubara N; Tomita N; Yanagi H; Yamanaka N
    Surgery; 2017 Feb; 161(2):422-432. PubMed ID: 27726913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal.
    Harewood GC; Kumar KS; Clain JE; Levy MJ; Nelson H
    J Gastroenterol Hepatol; 2004 Jul; 19(7):750-5. PubMed ID: 15209620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study.
    Shirouzu K; Akagi Y; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K;
    Ann Surg; 2011 Apr; 253(4):704-10. PubMed ID: 21475010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.